AI Summary

The U.S. Food and Drug Administration cleared a new blood test for marketing. The test, called PrecivityAD2, uses technology invented at Washington University School of Medicine in St. Louis to help diagnose Alzheimer’s disease early. C2N Diagnostics, a WashU‑based startup, developed and validated the test before FDA approval.

AI summaries can be wrong sometimes—always verify important details using the source article.